A 3D vascularized bone remodeling model combining osteoblasts and osteoclasts in a CaP nanoparticle-enriched matrix
Abstract
Aim: We aimed to establish a 3D vascularized in vitro bone remodeling model. Materials & methods: Human umbilical endothelial cells (HUVECs), bone marrow mesenchymal stem cells (BMSCs), and osteoblast (OBs) and osteoclast (OCs) precursors were embedded in collagen/fibrin hydrogels enriched with calcium phosphate nanoparticles (CaPn). We assessed vasculogenesis in HUVEC-BMSC coculture, osteogenesis with OBs, osteoclastogenesis with OCs, and, ultimately, cell interplay in tetraculture. Results: HUVECs developed a robust microvascular network and BMSCs differentiated into mural cells. Noteworthy, OB and OC differentiation was increased by their reciprocal coculture and by CaPn, and even more by the combination of the tetraculture and CaPn. Conclusion: We successfully developed a vascularized 3D bone remodeling model, whereby cells interacted and exerted their specific function.
References
- 1 . Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed. Res. Int. 2015, 421746 (2015).
- 2 . The cellular basis of bone remodeling: the quantum concept reexamined in light of recent advances in the cell biology of bone. Calcif. Tissue Int. 36(Suppl. 1), S37–S45 (1984).
- 3 . Role of angiogenesis on bone formation. Histol. Histopathol. 27(5), 559–566 (2012).
- 4 Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl Acad. Sci. USA 87(18), 7260–7264 (1990).
- 5 . Osteoclast progenitors promote bone vascularization and osteogenesis. Nat. Med. 20(11), 1238–1240 (2014).
- 6 . Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507(7492), 323–328 (2014).
- 7 Generation of 3D functional microvascular networks with human mesenchymal stem cells in microfluidic systems. Integr. Biol. (Camb.) 6(5), 555–563 (2014).
- 8 . Endothelial/pericyte interactions. Circ. Res. 97(6), 512–523 (2005).
- 9 . Role and regulation of vascularization processes in endochondral bones. Calcif. Tissue Int. 92(4), 307–323 (2013).
- 10 . Preclinical evaluation of injectable bone substitute materials. J. Tissue Eng. Regen. Med. 9(3), 191–209 (2015).
- 11 . Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials. Angiogenesis 15(2), 253–264 (2012).
- 12 Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc. Natl Acad. Sci. USA 112(1), 214–219 (2015).
- 13 Human in vitro 3D co-culture model to engineer vascularized bone-mimicking tissues combining computational tools and statistical experimental approach. Biomaterials 76, 157–172 (2016).
- 14 A 3D in vitro bone organ model using human progenitor cells. Eur. Cells Mater. 21, 445–458 (2011).
- 15 . Effect of osteoclast co-culture on the differentiation of human mesenchymal stem cells grown on bone graft granules. J. Biomater. Sci. Polym. Ed. 22(4–6), 789–808 (2011).
- 16 Effects of hydroxyapatite on endothelial network formation in collagen/fibrin composite hydrogels in vitro and in vivo. Acta Biomater. 10(7), 3091–3097 (2014).
- 17 . Calcium phosphate phases integrated in silica/collagen nanocomposite xerogels enhance the bioactivity and ultimately manipulate the osteoblast/osteoclast ratio in a human co-culture model. Acta Biomater. 9(1), 4878–4888 (2013).
- 18 Rational design of prevascularized large 3D tissue constructs using computational simulations and biofabrication of geometrically controlled microvessels. Adv. Healthc. Mater.
doi:10.1002/adhm.201500958 (2016) (Epub ahead of print). - 19 . Calcium phosphates as substitution of bone tissues. Prog. Solid State Chem. 32 (1), 1–31 (2004).
- 20 . Nano-hydroxyapatite and its applications in preventive, restorative and regenerative dentistry: a review of literature. Ann. Stomatol. (Roma) 5(3), 108–114 (2014).
- 21 . Nanostructured materials. Rep. Prog. Phys. 64(3), 297–381 (2001).
- 22 . High specific surface area in nanometric carbonated hydroxyapatite. Chem. Mater. 20(19), 3 (2008).
- 23 . Nanostructured ceramics in medical devices: applications and prospects. Overview Nanomaterials And Surfaces JOM 56(10), 38–43 (2004).
- 24 . Preparation of calcium hydroxyapatite nanoparticles using microreactor and their characteristics of protein adsorption. J. Phys. Chem. B 115(4), 653–659 (2011).
- 25 Biomimetic modification of synthetic hydrogels by incorporation of adhesive peptides and calcium phosphate nanoparticles: in vitro evaluation of cell behavior. Eur. Cells Mater. 22 359–376 (2011).
- 26 . Matrix elasticity directs stem cell lineage specification. Cell 126(4), 677–689 (2006).
- 27 . The synergetic effect of hydrogel stiffness and growth factor on osteogenic differentiation. Biomaterials 35(20), 5294–5306 (2014).
- 28 . Complex effect of hydroxyapatite nanoparticles on the differentiation and functional activity of human pre-osteoclastic cells. J. Biomed. Nanotechnol. 10(12), 3590–3600 (2014).
- 29 . Osteogenesis and trophic factor secretion are influenced by the composition of hydroxyapatite/poly(lactide-co-glycolide) composite scaffolds. Tissue Eng. A 16(1), 127–137 (2010).
- 30 . Bioceramic-mediated trophic factor secretion by mesenchymal stem cells enhances in vitro endothelial cell persistence and in vivo angiogenesis. Tissue Eng. A 18(13–14), 1520–1528 (2012).
- 31 Development of injectable organic/inorganic colloidal composite gels made of self-assembling gelatin nanospheres and calcium phosphate nanocrystals. Acta Biomater. 10(1), 508–519 (2014).
- 32 . Functionalization of oligo(poly(ethylene glycol)fumarate) hydrogels with finely dispersed calcium phosphate nanocrystals for bone-substituting purposes. J. Biomater. Sci. Polym. Ed. 18(12), 1547–1564 (2007).
- 33 Orthopedic bioactive implants: hydrogel enrichment of macroporous titanium for the delivery of mesenchymal stem cells and strontium. J. Biomed. Mater. Res. A 101(12), 3396–3403 (2013).
- 34 . Donor-matched mesenchymal stem cells from knee infrapatellar and subcutaneous adipose tissue of osteoarthritic donors display differential chondrogenic and osteogenic commitment. Eur. Cells Mater. 27, 298–311 (2014).
- 35 . Determination of the differentiation capacities of murines’ primary mononucleated cells and MC3T3-E1 cells. Cancer Cell Int. 10, 42 (2010).
- 36 . Physiology of bone formation, remodeling, and metabolism. In: Radionuclide and Hybrid Bone Imaging. Fogelman I, Gnanasegaran G, van der Wall H (Eds). Springer-Verlag. Berlin Heidelberg, 29–55 (2012).
- 37 . Bone remodeling rate and remodeling balance are not co-regulated in adulthood: implications for the use of activation frequency as an index of remodeling rate. J. Bone Miner. Res. 22(7), 1031–1036 (2007).
- 38 . 2D and 3D collagen and fibrin biopolymers promote specific ECM and integrin gene expression by vascular smooth muscle cells. J. Biomater. Sci. Polym. Ed. 19(10), 1279–1293 (2008).
- 39 . Bone strength: current concepts. Ann. N.Y. Acad. Sci. 1068 429–446 (2006).
- 40 . Fibrin structure and wound healing. J. Thromb. Haemost. 4(5), 932–939 (2006).
- 41 . Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 4(13), 3111–3123 (1990).
- 42 Proliferation-coupled osteoclast differentiation by RANKL: cell density as a determinant of osteoclast formation. Bone 81, 392–399 (2015).
- 43 Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: an in vitro osteoblast-osteoclast-endothelial cell co-culture study. Acta Biomater. 32, 298–308 (2015).
- 44 . Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J. 25(24), 5840–5851 (2006).
- 45 Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J. Clin. Invest. 123(2), 666–681 (2013).
- 46 Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 4(2), 111–121 (2006).
- 47 . Crosstalk of osteoblast and osteoclast precursors on mineralized collagen--towards an in vitro model for bone remodeling. J. Biomed. Mater. Res. A 95(3), 848–856 (2010).
- 48 . Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone. Tissue Eng. A 15(9), 2373–2383 (2009).
- 49 Angiogenic factors in bone local environment. Cytokine Growth Factor Rev. 24(3), 297–310 (2013).
- 50 Co-culture with endothelial progenitor cells promotes survival, migration, and differentiation of osteoclast precursors. Biochem. Biophys. Res. Commun. 430(2), 729–734 (2013).
- 51 . Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J. Cell. Biochem. 95(4), 827–839 (2005).
- 52 Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl Acad. Sci. USA 99(15), 9656–9661 (2002).
- 53 . 3D functional and perfusable microvascular networks for organotypic microfluidic models. J. Mater. Sci. Mater. Med. 26(5), 180 (2015).
- 54 . Human osteoblasts within soft peptide hydrogels promote mineralisation in vitro. J. Tissue Eng. 5, 2041731414539344 (2014).
- 55 . Reciprocal interactions between cells and extracellular matrix during remodeling of tissue constructs. Biophys. Chem. 100(1–3), 593–605 (2003).
- 56 . Nanoparticles and their potential for application in bone. Int. J. Nanomedicine 7, 4545–4557 (2012).
- 57 The effect of particle design on cellular internalization pathways. Proc. Natl Acad. Sci. USA 105(33), 11613–11618 (2008).
- 58 . Calcium phosphate nanoparticles in biomineralization and biomaterials. J. Mater. Chem. 18 3775–3787 (2008).
- 59 Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostability. Biomaterials 30(19), 3307–3317 (2009).
- 60 . The role of alkaline phosphatase in mineralization. Curr. Opin. Orthop. 18, 444–448 (2007).
- 61 Morphology-based prediction of osteogenic differentiation potential of human mesenchymal stem cells. PLoS One 8(2), e55082 (2013).
- 62 . Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake. Traffic 4(2), 113–125 (2003).
- 63 . Osteoclast lineage and function. Arch. Biochem. Biophys. 473(2), 132–138 (2008).